Table 2 Chromosomal imbalances as identified by CGH present in sporadic and familial adenomatous polyposis-related tumors

From: Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas

ID

CGH gains

CGH losses

No. of changes

F1

7q21–qter, 14q, 17q11–23, 18q11–12

10q, 15q, 17p, 18q12–qter

8

F2

8q23–qter, 11q11–13, 17q11–21, 19, 20

1p11–32, 4, 11q14–qter, 15q

9

F3

  

0

F4

8

 

1

F5

19q32–qter

 

1

S1

6p11–12, 12q14–21, 13q, 15q24–qter

2q21–24, 21

6

S2

12q13–15, 20

 

2

S3

7pter–q22, 8q (8q24–qter high copy), 13q (clear copy), 22

8p, 9p, 15q, 17p, 18

9

S4

8q, 13q

9p, 17q23–qter

4

S5

  

0

S6

1q23–qter, 5p, 16p, 19, 20q

 

5

S7

12p (clear copy), 17

18p

3

S8

12

 

1

S9

3p11–14, 6p11–21, 12q13–15, 12p, 14q12–21, 15q24–qter, 18p, 20q (high copy)

6p21–pter, 6q

10

S10

8q11–13, 8q23–qter, 5p11–13 (clear copy), 12q14–15. 17q22–qter, 20q

 

6

  1. F, FAP related tumors; S, sporadic tumors.